Patient-reported outcomes in non-muscle invasive bladder cancer: a mixed-methods systematic review.
Claudia RutherfordManish I PatelMargaret-Ann TaitDavid P SmithDaniel S J CostaShomik SenguptaMadeleine T KingPublished in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2020)
Treatments for NMIBC can cause symptoms and functional impairment during the acute treatment phase and reduce quality of life. Clinicians should be aware of these impairments to prepare patients for short-term sequelae and enable those with treatment options to exercise preferences in choosing among them. However, gaps in current evidence limit our understanding of PRO trajectories from diagnosis through to long-term survivorship and treatment effects.
Keyphrases
- patient reported outcomes
- systematic review
- muscle invasive bladder cancer
- end stage renal disease
- ejection fraction
- depressive symptoms
- randomized controlled trial
- newly diagnosed
- liver failure
- palliative care
- physical activity
- high intensity
- clinical trial
- meta analyses
- combination therapy
- prognostic factors
- study protocol
- decision making
- replacement therapy
- resistance training
- intensive care unit
- hepatitis b virus